Cartesian Therapeutics
RNAC
RNAC
48 hedge funds and large institutions have $235M invested in Cartesian Therapeutics in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
4% more funds holding
Funds holding: 46 → 48 (+2)
0.56% more ownership
Funds ownership: 1.56% → 2.12% (+0.56%)
Holders
48
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$22.2M | |
| 2 | +$18.6M | |
| 3 | +$13M | |
| 4 |
BlackRock
New York
|
+$5.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.75M |
Top Sellers
| 1 | -$11.8M | |
| 2 | -$1.37M | |
| 3 | -$452K | |
| 4 |
HP
Hikari Power
Tokyo,
Japan
|
-$349K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$192K |